BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10774176)

  • 21. [Paraneoplastic encephalomyelitis/sensory neuropathy].
    Tanaka M; Tanaka K
    Ryoikibetsu Shokogun Shirizu; 2000; (31):68-72. PubMed ID: 11269191
    [No Abstract]   [Full Text] [Related]  

  • 22. BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis.
    Sabater L; Gómez-Choco M; Saiz A; Graus F
    J Neuroimmunol; 2005 Dec; 170(1-2):186-90. PubMed ID: 16165222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dysphagia and constipation as clinical manifestations of anti-Hu paraneoplastic syndrome].
    Guardiola H; Vilaseca B; Martí S; de la Torre N
    Med Clin (Barc); 2004 Sep; 123(10):398-9. PubMed ID: 15482710
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-Hu antibodies in Merkel cell carcinoma.
    Greenlee JE; Steffens JD; Clawson SA; Hill K; Dalmau J
    Ann Neurol; 2002 Jul; 52(1):111-5. PubMed ID: 12112058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Small cell lung cancer associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
    Fujii M; Tanaka H; Saito T; Kaneko S; Teramoto S; Murakami S; Omote T; Kashiwagi M; Tanaka K; Abe S
    Nihon Kokyuki Gakkai Zasshi; 1999 Dec; 37(12):992-6. PubMed ID: 10707541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological course of long-term surviving patients with SCLC and anti-Hu syndrome.
    Poepel A; Jarius S; Heukamp LC; Urbach H; Elger CE; Bien CG; Voltz R
    J Neurol Sci; 2007 Dec; 263(1-2):145-8. PubMed ID: 17706677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe paraneoplastic gastroparesis associated with anti-Hu antibodies preceding the manifestation of small-cell lung cancer.
    Nguyen-tat M; Pohl J; Günter E; Manner H; Plum N; Pech O; Ell C
    Z Gastroenterol; 2008 Mar; 46(3):274-8. PubMed ID: 18322883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic sensory neuropathy].
    Asahina M; Hattori T
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):363-6. PubMed ID: 11031970
    [No Abstract]   [Full Text] [Related]  

  • 29. [Paraneoplastic ataxia associated to anti CV2 antibodies].
    Medrano V; Sempere AP; González E
    Rev Neurol; 2003 Jan 16-31; 36(2):131-3. PubMed ID: 12589599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spinal cord paraneoplastic syndromes].
    Marés-Segura R
    Rev Neurol; 2000 Dec 16-31; 31(12):1219-23. PubMed ID: 11205563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of paraneoplastic sensory neuronopathy and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient.
    Kawahara M; Furuse K; Kodama N; Ogawara M; Kubota K; Yamamoto S; Tada H; Mori T; Miyawaki Y; Hirohashi S
    Jpn J Clin Oncol; 1994 Aug; 24(4):224-7. PubMed ID: 8072202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature.
    Mancuso M; Orsucci D; Bacci A; Caldarazzo Ienco E; Siciliano G
    Arch Ital Biol; 2011 Sep; 149(3):318-22. PubMed ID: 22028093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
    King PH; Redden D; Palmgren JS; Nabors LB; Lennon VA
    J Autoimmun; 1999 Dec; 13(4):435-43. PubMed ID: 10585760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of small cell lung cancer with paraneoplastic cerebellar degeneration and anti-voltage-gated calcium channel antibody].
    Shirai S; Sukoh N; Yamamoto H; Suzuki I; Kamimura A; Yoshida K; Suzuki A; Inoue M; Watanabe N
    Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):40-4. PubMed ID: 11296385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.
    Vernino S; Tuite P; Adler CH; Meschia JF; Boeve BF; Boasberg P; Parisi JE; Lennon VA
    Ann Neurol; 2002 May; 51(5):625-30. PubMed ID: 12112110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature.
    Raibagkar P; Ho D; Gunturu KS; Srinivasan J
    J Neuroimmunol; 2020 Apr; 341():577184. PubMed ID: 32058173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer.
    Hiasa Y; Kunishige M; Mitsui T; Kondo S; Kuriwaka R; Shigekiyo S; Kanematsu T; Satake N; Bando Y; Kondo A; Endo I; Oshima Y; Matsumoto T
    Clin Neurol Neurosurg; 2003 Dec; 106(1):47-9. PubMed ID: 14643918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Subacute neuropathy, multiple cancers, and Gougerot-Sjögren syndrome: contribution of anti-Hu antibody].
    Auf G; Benyahia B; Orcel B; Beigelman C; Delattre JY
    Rev Neurol (Paris); 2001 Feb; 157(2):219-21. PubMed ID: 11283468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.